EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

Stable Disease Achieved with Sequential Immunochemotherapy and Anti-Angiogenic TKI in Recurrent Metastatic Hidradenocarcinoma: A Case Report and Literature Review

Shidi Wen, Lu Wang, Ying Jiang, Zhiyang Zhang, Yuejuan Cheng

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.080462 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Oncology Research, 2026. Verfasst von Shidi Wen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medicine College, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Sweat Gland Neoplasms, Angiogenesis Inhibitors, Neoplasm Recurrence, Local. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hidradenocarcinoma is a rare and highly aggressive malignancy with limited therapeutic options. This report describes the clinical course and treatment response of a patient with recurrent metastatic hidradenocarcinoma treated with sequential immunochemotherapy combined with anti-angiogenic therapy, with the aim of providing further insight into potential treatment strategies for this rare malignancy. Case Description: A 60-year-old male initially presented in 2020 with scrotal erythema and was diagnosed with hidradenocarcinoma after surgery. Despite surgical treatment, he developed recurrent disease with diffuse metastases. First-line chemoimmunotherapy (sintilimab, cisplatin, 5-fluorouracil; six cycles) achieved a progression-free survival (PFS) of 6 months. Following disease progression, second-line therapy (toripalimab, nab-paclitaxel, anlotinib; eight cycles) was administered, resulting in sustained stable disease with a subsequent PFS of 8 months. Radiotherapy was used for brain metastases. The total follow-up duration exceeded 4 years until the patient was lost to follow-up in December 2024.

Conclusions

This case suggests that sequential programmed death-1 (PD-1) blockade-based immunochemotherapy combined with anti-angiogenic therapy may provide clinically meaningful disease control in metastatic hidradenocarcinoma, even in the setting of low programmed death-ligand 1 (PD-L1) expression and microsatellite stability. Our findings support a potential role for immunotherapy in sweat gland carcinomas and highlight the importance of individualized multimodal treatment strategies for this rare malignancy. Further studies are needed to identify predictive biomarkers and establish optimal therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsSweat Gland NeoplasmsAngiogenesis InhibitorsNeoplasm Recurrence, LocalProtein Kinase InhibitorsImmunotherapyHumansMaleMiddle AgedQuinolinesAntibodies, Monoclonal, HumanizedCisplatinFluorouracilPaclitaxelIndoles

Stichwörter der Autor:innen

Hidradenocarcinomacase reportextramammary Paget diseaseimmunotherapysweat gland carcinoma

Substanzen

Angiogenesis InhibitorsQuinolinesProtein Kinase InhibitorssintilimabAntibodies, Monoclonal, HumanizedanlotinibtoripalimabCisplatinFluorouracilPaclitaxel

Autor:innen und Institutionen

  • Clinical Medicine College, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Zitieren

APA

Wen, S., Wang, L., Jiang, Y., Zhang, Z., & Cheng, Y. (2026). Stable Disease Achieved with Sequential Immunochemotherapy and Anti-Angiogenic TKI in Recurrent Metastatic Hidradenocarcinoma: A Case Report and Literature Review. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.080462

Vancouver

Wen S, Wang L, Jiang Y, Zhang Z, Cheng Y. Stable Disease Achieved with Sequential Immunochemotherapy and Anti-Angiogenic TKI in Recurrent Metastatic Hidradenocarcinoma: A Case Report and Literature Review. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.080462

BibTeX
@article{Wen2026,
  author = {Wen, Shidi and Wang, Lu and Jiang, Ying and Zhang, Zhiyang and Cheng, Yuejuan},
  title = {Stable Disease Achieved with Sequential Immunochemotherapy and Anti-Angiogenic TKI in Recurrent Metastatic Hidradenocarcinoma: A Case Report and Literature Review},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.080462}
}
Kostenlos starten →